The precision of T1 hypointense lesion volume quantification in multiple sclerosis treatment trials: a multicenter study

Abstract

The volume of hypointense lesions on T1 weighted brain MRI represents an increasingly used MR endpoint in phase III MS treatment trials. In this study we evaluated the reproducibility of hypointense T1 lesion volume quantification in a cohort of Multiple Sclerosis (MS) patients. The gadolinium enhanced T1 weighted brain MR images of 33 MS patients from three European centers were used in this study. These images were acquired as part of a phase III trial of interferon beta-1b in secondary progressive MS. The MRI machine manufacturers and imaging parameters varied according to the MRI acquisition center. Three experienced observers used a semi-automated local thresholding technique to quantify the hypointense T1 lesion volume on two occasions, separated by a delay. The intra and inter observer coefficients of variation were 3.7% and 4.9% respectively, with similar values derived for images obtained at all three sites. There was a generally high level of agreement between the lesion volumes obtained by the three raters. However, a modest but significant measurement drift was identified between the first and second sessions for one of the three raters, highlighting the very real possibility of measurement drift even for experienced observers. Our results support the increasing role for T1 hypointense lesion volume as an outcome measure in multicenter phase III MS treatment trials.

Keywords

T1 black hole magnetic resonance imaging multiple sclerosis

Get full access to this article

View all access options for this article.

References

Paty DW , Li DKB , the UBC MS/MRI Study Group , the IFNB Multiple Sclerosis Study Group . (1993) Interferon beta-1b is effective in relapsing remitting MS. MRI analysis results of a multicenter, randomised, double blind, placebo controlled trial . Neurology 43: 662-667 .

Jacobs LD et al. (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis . Ann Neurol 39: 285-294 .

Simon JH et al. (1998) Magnetic resonance studies of intramuscular interferon b-1a for relapsing multiple sclerosis . Ann Neurol 43: 79-87 .

PRISMS Study Group . (1998) Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis . Lancet 352: 1498-1504 .

European Study Group on interferon b-1b in secondary progressive .MS (1998) Placebo-controlled multicenter randomised trial of interferon b-1b in treatment of secondary progressive multiple sclerosis . Lancet 352: 1491-1497 .

Zhao GJ et al. (1997) Clinical and magnetic resonance imaging changes correlate in a clinical trial monitoring cyclosporine therapy for multiple sclerosis . JNeuroimag 7: 1-7 .

Miller DH et al. (1996) Guidelines for the use of magnetic resonance techniques in monitoring the treatment of MS . Ann Neurol 39: 6-16 .

Truyen L et al. (1996) Accumulation of hypointense lesions (`black holes') on T1 spin-echo MRI correlates with disease progression in multiple sclerosis . Neurology 47: 1469-1476 .

Barkhof F , McGowan JC , van Waesberghe JH , Grossman RI. (1998) Hypointense multiple sclerosis lesions on T1- weighted spin echo magnetic resonance images: their contribution in understanding multiple sclerosis evolution . J Neurol Neurosurg Psychiatry 64 (Suppl 1): S77-S79 .

10.

McGowan JC , Filippi M , Campi A , Grossman RI. (1998) Magnetisation transfer imaging: theory and application to multiple sclerosis . J Neurol Neurosurg Psychiatry 64 (Suppl 1): S66-S69 .

11.

Losseff NA. (1996) Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression . Brain 119: 701-708 .

12.

Losseff NA et al. (1996) Progressive cerebral atrophy in multiple sclerosis. A serial study . Brain 119: 2009-2019 .

13.

Polman C et al. (1995) Interferon beta-1b in secondary progressive multiple sclerosis-outline of the clinical trial . Multiple Sclerosis 1: S51-S54 .

14.

van Walderveen MAA et al. (1995) Correlating MRI and clinical disease: Relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images . Neurology 5: 1684-1690 .

15.

Sailer M et al. (1998) The relationship between T1 lesion load and cerebral atrophy in multiple sclerosis . JNeurol 245: 371-371 .

16.

Wicks DAG et al. (1992) Volume measurement of multiple sclerosis lesions with magnetic resonance images. A preliminary study . Neuroradiology 34: 475-479 .

17.

Filippi M et al. (1995) Intra- and inter-observer variability of brain MRI lesion volume measurements in multiple sclerosis. A comparison of techniques . Brain 118: 1593-1600 .

18.

Grimaud J et al. (1996) Quantification of MRI lesion load in MS: a comparison of three computer-assisted techniques . Magn Reson Imag 14: 495-505 .

19.

Molyneux PD et al. (1998) Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques . J Neurol Neurosurg Psychiatry 65: 42-47 .

20.

Dunn OJ , Clark VA. (1987) Applied statistics: analysis of variance and regression. 2nd edn. Wiley: New York .

21.

Efron B , Tibshirani RJ. (1993) An introduction to the bootstrap. Chapman & Hall Inc: New York .

22.

Plummer DL. (1992) Dispimage: a display and analysis tool for medical images . Rivista di Neuroradiologia 5: 489-495 .

23.

Whitaker JN , McFarland HF , Rudge P , Reingold SC. (1995) Outcomes assessment in multiple sclerosis clinical trials: a critical analysis . Multiple Sclerosis 1: 37-47 .

24.

O'Riordan JI et al. (1998) T1 hypointense lesion load in secondary progressive multiple sclerosis: a comparison ofpreversuspostcontrastloadsandofmanualversus semi automated threshold techniques for lesion segmentation . Multiple Sclerosis 4: 408-412 .

25.

Filippi M et al. (1997) Interscanner variation in brain MRI lesion load measurements in MS: implications for clinical trials . Neurology 49: 371-377 .